Aurora Cannabis Skyrockets After Earnings: Should You Buy Into the Rally?
On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...
Aurora Cannabis: Strong Buy On Blowout Results And Constructive Outlook
As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...
Aurora Cannabis (ACB) Trades at a Discount Despite Record-Breaking Quarter
Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...
Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the ...
Aurora Cannabis Inc. (TSE:ACB) Given Average Recommendation of “Moderate Buy” by Analysts
Aurora Cannabis Inc. (TSE:ACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. Three ...
ETF Daily News3d
Roth Capital Reduces Earnings Estimates for Aurora Cannabis
The company produces, distributes, and sells medical and consumer cannabis products in Canada. Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a ...
Le Lézard5h
Government of Canada takes further action to address fentanyl precursor chemicals
We are accelerating Canada's work to detect, disrupt, and dismantle the fentanyl trade. Illegal drugs are having a devastating impact on people and communities, including creating security challenges ...
Zacks.com on MSN4d
Is Beam Therapeutics (BEAM) Outperforming Other Medical Stocks This Year?
Here is how Beam Therapeutics Inc. (BEAM) and Aurora Cannabis Inc. (ACB) have performed compared to their sector so far this year.